Luis Brieva Ruiz
Grau: Doctor/a
973 705 367
lbrieva.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/E-8505-2019
Grups
Publicacions
-
Gil-Sanchez, A; Canudes, M; Valcheva, P; Nogueras, L; González-Mingot, C; Hervás, JV; Peralta, S; Solana, M; Brieva, L
Effects of Vortioxetine on Cognition and Fatigue in Patients with Multiple Sclerosis and Depression: A Case Series Study
CNS & Neurological Disorders-Drug Targets 23 395-401. .
-
Sancho--Saldaña, A; Gil-Sánchez, A; González-Mingot, C; Peralta, S; Solana, MJ; Torres, P; Juanes, A; Quibus, L; Ruiz, E; Sanpedro, E; Quirant-Sánchez, B; Martínez-Cáceres, E; Tello, CR; Presas-Rodríguez, S; Rubio, SG; Baron, BP; Ramio-Torrenta, L; Sotoca, J; González-Suarez, I; Eichau, S; Prieto-Gonzalez, JM; Quilez, MRB; Sabin-Muñoz, J; Sánchez-López, AJ; Calatayud, GL; Calles, C; Sempere, AP; Garces, M; Carmona, O; Moral, E; Hervas, JV; Blanco, Y; Sola-Valls, N; Lara, NT; Forero, L; Brieva, L
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study
Journal of Clinical Medicine 12 -. .
-
Brochet, B; Solari, A; Lechner-Scott, J; Piehl, F; Langdon, D; Hupperts, R; Selmaj, K; Patti, F; Brieva, L; Maida, EM; Alexandri, N; Smyk, A; Nolting, A; Keller, B; Montalban, X; Havrdova, EK
Improvements in quality of life over 2 years with cladribine tablets in people with relapsing multiple sclerosis: The CLARIFY-MS study
MULTIPLE SCLEROSIS JOURNAL 29 1808-1818. .
-
Mingot, CG; Lasaosa, SS; Campas, LC; Canaval, LC; Sánchez, AG; Ruiz, LB; Alonso, MCM; Moncusi, SP; Marsal, JV; Carner, SC; García, FP
Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study
SCIENTIFIC REPORTS 13 19416-19416. .
-
Koch, MW; Moral, E; Brieva, L; Mostert, J; Strijbis, EM; Comtois, J; Repovic, P; Bowen, JD; Wolinsky, JS; Lublin, FD; Cutter, G
Relapse recovery in relapsing-remitting multiple sclerosis: An analysis of the CombiRx dataset
MULTIPLE SCLEROSIS JOURNAL 29 1776-1785. .
-
Fernández O; Montalban X; Agüera E; Aladro Y; Alonso A; Arroyo R; Brieva L; Calles C; Costa-Frossard L; Eichau S; García-Domínguez JM; Hernández MA; Landete L; Llaneza M; Llufriu S; Meca-Lallana JE; Meca-Lallana V; Mongay-Ochoa N; Moral E; Oreja-Guevara C; Ramió-Torrentà L; Téllez N; Romero-Pinel L; Rodríguez-Antigüedad A
XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (II).
REVISTA DE NEUROLOGIA 77 47-60. .
-
Fernández, O; Montalban, X; Agüera, E; Aladro, Y; Alonso, A; Arroyo, R; Brieva, L; Calles, C; Costa-Frossard, L; Eichau, S; García-Domínguez, JM; Hernández, MA; Landete, L; Llufriu, MLS; Meca-Lallana, JE; Meca-Lallana, V; Mongay-Ochoa, N; Moral, E; Oreja-Guevara, C; Ramió-Torrentà, L; Téllez, N; Romero-Pinel, L; Rodríguez-Antigüedad, A
15th Post-ECTRIMS Meeting: a review of the latest developments presented at the 2022 ECTRIMS Congress (Part I)
REVISTA DE NEUROLOGIA 77 19-30. .
-
González-Mingot, C; Miana-Mena, FJ; Iñarrea, PJ; Iñiguez, C; Capablo, JL; Osta, R; Gil-Sánchez, A; Brieva, L; Larrodé, P
Mitochondrial Aconitase Enzymatic Activity: A Potential Long-Term Survival Biomarker in the Blood of ALS Patients
Journal of Clinical Medicine 12 -. .
-
Torres P; Sancho-Saldaña A; Gil Sánchez A; Peralta S; Solana MJ; Bakkioui S; González-Mingot C; Quibus L; Ruiz-Fernández E; San Pedro-Murillo E; Brieva L
A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies.
JOURNAL OF NEUROLOGY 270 1-12. .
-
Lleixà C; Caballero-Ávila M; Pascual-Goñi E; Martín-Aguilar L; Vidal N; Tejada C; Valdés-Hevia E; Zárate E; Vesperinas A; Collet R; Franco-Leyva T; Martínez-Martínez L; Moga E; Cortés-Vicente E; Rojas-García R; Gómez-Anson B; Gil A; González-Mingot C; Brieva L; Martínez-Yélamos S; Querol L
Antibodies against the flotillin-1/2 complex in patients with multiple sclerosis.
Brain Communications 5 -. .
-
Monreal, E; Fernandez-Velasco, JI; Garcia-Sanchez, MI; Sainz de la Maza S; Llufriu, S; Alvarez-Lafuente, R; Casanova, B; Comabella, M; Ramio-Torrenta, L; Martinez-Rodriguez, JE; Brieva, L; Saiz, A; Eichau, S; Cabrera-Maqueda, JM; Villarrubia, N; Espiño M; Perez-Miralles, F; Montalban, X; Tintore, M; Quiroga-Varela, A; Dominguez-Mozo, MI; Rodriguez-Jorge, F; Chico-Garcia, JL; Lourido, D; Alvarez-Cermeno, JC; Masjuan, J; Costa-Frossard, L; Villar, LM
Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy Drugs.
JAMA Neurology 80 397-403. .
-
de la Maza, SS; Gómez-Ballesteros, R; Borges, M; Martín-Martínez, J; Sotoca, J; Alonso, A; Caminero, AB; Borrega, L; Sánchez-Menoyo, JL; Barrero-Hernández, FJ; Calles, C; Brieva, L; Blasco-Quílez, MR; García-Soto, JD; del Campo-Amigo, M; Navarro-Cantó, L; Agüera, E; Garcés-Redondo, M; Carmona, O; Gabaldón-Torres, L; Forero, L; Hervàs, M; Medrano, N; Maurino, J; Castillo-Triviño, T
Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approach
Multiple Sclerosis Journal-Experimental Translational And Clinical 9 -. .
Projectes
- EMCOVID-19: Esclerosis Múltiple y COVID-19
- "Registro de pacientes con esclerosis múltiple (EM) tratados con Natalizumab en España"
- UTILIDAD DE LA REALIZACION DE SECUENCIAS DE DIFUSION Y LA DETERMINACION DE BIOMARCADORES EN EL PRONOSTICO DE LOS PACIENTES CON UN ATAQUE ISQUEMICO TRANSITORIO
